No Data
No Data
CareDx Is Maintained at Buy by Craig-Hallum
CareDx Is Maintained at Buy by Craig-Hallum
Analysts Offer Insights on Healthcare Companies: CareDx (CDNA), Amgen (AMGN) and Orasure Technologies (OSUR)
Express News | CareDx, Inc. : Craig-Hallum Raises Target Price to $22 From $15
Landmark Study Shows CareDx's HeartCare Outperforms Dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes With Fewer Biopsies
HeartCare Results Effectively Stratified Patients at Highest Risk for Acute Cellular Rejection Cardiologists Performed the Fewest Biopsies After Dual Negative HeartCare Results Compared to Single or Dual Positive
Express News | HC Wainwright & Co. Reiterates Neutral on CareDx
Balanced Outlook for CareDx: Strong Performance Amid Rising Competition
No Data